Virus Monopolizes Host’s Repairmen

Human cytomegalovirus fixes its broken DNA by exclusively co-opting its host’s repair proteins.

Written byEd Yong
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

HCMV-infected cellWikipedia, NephronHuman cells have several pathways for repairing damage to DNA, but those infected by human cytomegalovirus (HCMV) have no such recourse. Researchers at the University of Idaho have found that this virus can monopolize its host’s repair proteins, so they exclusively fix damage to the virus’s genome but not the host’s.

“If the virus co-opts the repair machinery for its own good, a cell's normal capacity to repair itself might be disabled,” said Lee Fortunato from the University of Idaho, who led the new study, published today (29 November) in PLOS Pathogens. And that’s exactly what she and her colleagues found.

HCMV can itself damage host DNA, breaking both strands of the double helix at specific points. Although the cell responds by mobilizing repair proteins, most of these repairs are never finished.

This is partly because, as Fortunato showed in earlier studies, HCMV impounds some repair proteins in its replication centers—large structures within the host nucleus where the virus reproduces itself. “I started thinking about whether the virus was absconding with what it needed for its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies